T
Timothy Craig Allen
Researcher at University of Texas Medical Branch
Publications - 39
Citations - 1828
Timothy Craig Allen is an academic researcher from University of Texas Medical Branch. The author has contributed to research in topics: Pulmonary pathology & Medical malpractice. The author has an hindex of 16, co-authored 39 publications receiving 1342 citations. Previous affiliations of Timothy Craig Allen include Cornell University & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Acute Lung Injury: A Clinical and Molecular Review
TL;DR: There are no viable predictive molecular biomarkers for predicting the severity of ARDS, or molecular-based ARDS therapies, and the proinflammatory cytokines TNF-α (tumor necrosis factor α), interleukin (IL-1β), IL-6, IL-8, and IL-18 are among the most promising as biomarker for predicting morbidity and mortality.
Journal ArticleDOI
Guidelines for pathologic diagnosis of Malignant Mesothelioma: 2017 Update of the consensus statement from the International Mesothelioma Interest Group
Aliya N. Husain,Thomas V. Colby,Nelson G. Ordóñez,Timothy Craig Allen,Richard Attanoos,Mary Beth Beasley,Kelly J. Butnor,Lucian R. Chirieac,Andrew Churg,Sanja Dacic,Françoise Galateau-Sallé,Allen R. Gibbs,Allen M. Gown,Thomas Krausz,Leslie A. Litzky,Alberto M. Marchevsky,Andrew G. Nicholson,Victor L. Roggli,Anupama Sharma,Anupama Sharma,William D. Travis,Ann E. Walts,Mark R. Wick +22 more
TL;DR: These guidelines are meant to be a practical diagnostic reference for the pathologist, however, some new pathologic predictors of prognosis and response to therapy are also included.
Journal ArticleDOI
Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.
Deepali Jain,Timothy Craig Allen,Dara L. Aisner,Mary Beth Beasley,Philip T. Cagle,Vera Luiza Capelozzi,Lida P. Hariri,Sylvie Lantuejoul,Ross A. Miller,Mari Mino-Kenudson,Sara E. Monaco,Andre L. Moreira,Kirtee Raparia,Natasha Rekhtman,Anja C. Roden,Sinchita Roy-Chowdhuri,Gilda da Cunha Santos,Erik Thunnissen,Giancarlo Troncone,Marina Vivero +19 more
TL;DR: A review of the current status of the literature regarding ROSE of EBUS-TBNA in the diagnosis of lung cancer can be found in this paper, where the authors provide an overview of their work.
Journal ArticleDOI
Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society.
Lynette M. Sholl,Dara L. Aisner,Timothy Craig Allen,Mary Beth Beasley,Alain C. Borczuk,Philip T. Cagle,Philip T. Cagle,Vera Luiza Capelozzi,Sanja Dacic,Lida P. Hariri,Keith M. Kerr,Sylvie Lantuejoul,Mari Mino-Kenudson,Kirtee Raparia,Natasha Rekhtman,Sinchita Roy-Chowdhuri,Eric Thunnissen,Ming-Sound Tsao,Yasushi Yatabe +18 more
TL;DR: Facing a proliferation of PD-L1 immunohistochemistry clones, staining platforms, and scoring criteria, the pathologist must decide on the feasibility of introducing a newly approved companion diagnostic assay that may require purchase not only of a specific antibody kit but of a particular staining platform.
Journal ArticleDOI
Biomarker testing in lung carcinoma cytology specimens: A perspective from members of the Pulmonary Pathology Society
Sinchita Roy-Chowdhuri,Dara L. Aisner,Timothy Craig Allen,Mary Beth Beasley,Alain C. Borczuk,Philip T. Cagle,Philip T. Cagle,Vera Luiza Capelozzi,Sanja Dacic,Gilda da Cunha Santos,Gilda da Cunha Santos,Lida P. Hariri,Keith M. Kerr,Sylvie Lantuejoul,Mari Mino-Kenudson,Andre L. Moreira,Kirtee Raparia,Natasha Rekhtman,Lynette M. Sholl,Eric Thunnissen,Ming-Sound Tsao,Ming-Sound Tsao,Marina Vivero,Yasushi Yatabe +23 more
TL;DR: A large fraction of lung cancers are diagnosed by aspiration or exfoliative cytology specimens, and thus, optimizing strategies to triage and best use the tissue for diagnosis and biomarker studies forms a critical component of lung cancer management.